ArticleCancers2026

Feasibility and Safety of Repeated Intraperitoneal Platinum and Pegylated Liposomal Doxorubicin for First Recurrent Ovarian Cancer: A Preliminary Retrospective Comparative Study.

Wan-Hua Ting et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.